Abramenko I V, Gluzman D F, Sklyarenko L M, Pisnyachevskaya G V, Pinchouk V G
R.E. Kavetsky Institute for Oncology Problems, Academy of Sciences, Ukrainian S.S.R. Kiev.
Anticancer Res. 1991 Mar-Apr;11(2):629-34.
A panel of markers, including MAbs to different epitopes of CEA, B 6.2, detection of AP activity and lectin receptors (PNA, HPL, SBA, LAL, LcL) for cell identification in pleural effusions, is proposed. Using immunocytochemical methods cancer cells were determined in all 80 cytological positive and in 13 from 21 cytologically negative cancer effusions. The reaction was not observed in 45 benign effusions. The panel was unsuccessful to determine the tumor cell origin. The immunophenotypic features of reactive transformed lymphocytes in effusions were described and the criteria for diagnosis of B-cell and T-cell NHL were present. By means of these criteria lymphomatous cells in serous effusions of seven patients were revealed.
有人提出了一组标志物,包括针对癌胚抗原(CEA)不同表位的单克隆抗体、B 6.2、碱性磷酸酶(AP)活性检测以及用于胸腔积液中细胞鉴定的凝集素受体(PNA、HPL、SBA、LAL、LcL)。采用免疫细胞化学方法,在所有80例细胞学阳性以及21例细胞学阴性的癌性积液中的13例中检测到了癌细胞。45例良性积液中未观察到反应。该组标志物未能确定肿瘤细胞的来源。描述了积液中反应性转化淋巴细胞的免疫表型特征,并给出了B细胞和T细胞非霍奇金淋巴瘤(NHL)的诊断标准。通过这些标准,在7例患者的浆液性积液中发现了淋巴瘤细胞。